Metformin increases plasma ghrelin in Type 2 diabetes |
| |
Authors: | Matthew P Doogue Evan J Begg M Peter Moore Helen Lunt Chris J Pemberton Mei Zhang |
| |
Institution: | 1.Department of Clinical Pharmacology, Christchurch, New Zealand;2.Department of Diabetes Centre, Canterbury District Health Board, Christchurch, New Zealand;3.Department of Medicine, University of Otago, Christchurch, New Zealand |
| |
Abstract: | AIMSMetformin treatment of Type 2 diabetes is not usually associated with weight gain, and may assist with weight reduction. Plasma ghrelin concentrations are inversely associated with obesity and food intake. Metformin might therefore affect ghrelin concentrations, although previous studies have shown variable results in this regard. The primary aim of this study was to determine the effect of metformin on plasma ghrelin, appetite and satiety in patients with Type 2 diabetes.METHODSEighteen patients with Type 2 diabetes were studied before and after 6 weeks of metformin treatment, which was titrated to 1 g b.d. On the study days patients were fed standard meals of 390 kcal at 08.00 and 12.30 h, plasma samples were collected at 15- and 30-min intervals, and appetite and satiety were measured on visual analogue scales. Changes in the area under the concentration–time curves (AUCs) of plasma ghrelin, insulin, glucose, appetite and satiety were assessed and examined for correlations with metformin AUCs. Changes in fasting adiponectin and leptin were also measured.RESULTSTreatment with metformin increased the mean AUC (07.30–16.30 h) of plasma ghrelin by 24% (P= 0.003), while decreasing those of glucose by 19% (P < 0.001) and insulin by 19% (P= 0.001). No changes were detected in hunger and satiety, or in fasting adiponectin or leptin concentrations. There were no clear correlations between metformin plasma concentrations (AUC) and changes in plasma glucose, insulin or ghrelin.CONCLUSIONSTreatment of Type 2 diabetes with metformin was associated with increased plasma ghrelin concentrations, without associated changes in hunger and satiety. |
| |
Keywords: | ghrelin insulin metformin type 2 diabetes |
|
|